BEGIN:VCALENDAR VERSION:2.0 PRODID:-//hacksw/handcal//NONSGML v1.0//EN BEGIN:VEVENT UID:a27593f1afe2f63814d9d8c5d4ad209b DTSTAMP:20260403T180635Z DTSTART:20241014T160000 DTEND:20241014T173000 SUMMARY:WHS - Milestones and Challenges in Tackling AMR DESCRIPTION:\nKEY 02 – Milestones and Challenges in Tackling AMR\n \nOct. 14, 2024, CEST: 04:00 PM - 05:30 PM / UTC: 02:00 PM - 03:30 PM\n\n \nDigital Session: https://www.youtube.com/watch?v=m47v_WIf6wA\n \n\nKeynote (KEY 02) - Europe\nAntimicrobial Resistance (AMR) remains a growing and concerning global challenge, despite decades of concerted effort. We’ve tried raising the alarm with terrifying statistics and compelling economic arguments, yet AMR continues to be overshadowed by other priorities. How do we move forward to secure the commitment and action needed to address AMR effectively?\n\nThis dynamic keynote session will explore key milestones in understanding, preventing, and managing AMR. The discussion will offer the latest insights on where we stand, address what is holding back progress, and showcase successful interventions. In the wake of the United Nations (UN) High-Level Meeting on AMR, this session will also address persistent challenges, including the slow pace of new drug development, inadequate regulatory frameworks, and the need for global coordination.\n\nUltimately, this session seeks to inspire the World Health Summit (WHS) audience with greater urgency, alignment, and ambition to bring commitments and goals for AMR to fruition from a policy and systems perspective. By examining both achievements and obstacles, this session aims to foster collective action to mitigate AMR's impact on global health. Join us in navigating the complex landscape of AMR, celebrate progress, and address the roadblocks that remain.\n \n\nHosts:\nFederal Ministry of Health of Germany (BMG)\n\n\nModerators:\n\nLatifat Okara\nEconomist Impact | Principal for Health Policy and Insights | United States of America\n \n\n\n\n\nSpeakers:\n\nDr. Muna Abu Sin\nFederal Ministry of Health (BMG) | Ambassador on Antimicrobial Resistance | Germany\n \n \n\n\nDr. Abdullah Algwizani\nPublic Health Authority | CEO | Saudi Arabia\n \n \n\n\nProf. Dame Sally Davies\nUK Special Envoy on Antimicrobial Resistance | United Kingdom\n \n \n\n\nDr. Arshnee Moodley\nCGIAR | Antimicrobial Resistance Hub | Lead | Kenya\n \n \n\n\nDr. David Reddy\nInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Director-General | Switzerland\n \n \n\n\nDr. John-Arne Røttingen\nWellcome Trust | CEO | United Kingdom\n \n \n\n\nProf. Dr. Orazio Schillaci\nMinister of Health | Italy\nVideo Participation\n \n\n\nProf. Dr. Abdellahi Sidi Mohamed Weddih\nMinister of Health | Mauritania\n\n\n X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\n

KEY 02 – Milestones and Challenges in Tackling AMR


 


Oct. 14, 2024, CEST: 04:00 PM - 05:30 PM / UTC: 02:00 PM - 03:30 PM



 


Digital Session: https://www.youtube.com/watch?v=m47v_WIf6wA


 



Keynote (KEY 02) - Europe


Antimicrobial Resistance (AMR) remains a growing and concerning global challenge, despite decades of concerted effort. We’ve tried raising the alarm with terrifying statistics and compelling economic arguments, yet AMR continues to be overshadowed by other priorities. How do we move forward to secure the commitment and action needed to address AMR effectively?

This dynamic keynote session will explore key milestones in understanding, preventing, and managing AMR. The discussion will offer the latest insights on where we stand, address what is holding back progress, and showcase successful interventions. In the wake of the United Nations (UN) High-Level Meeting on AMR, this session will also address persistent challenges, including the slow pace of new drug development, inadequate regulatory frameworks, and the need for global coordination.

Ultimately, this session seeks to inspire the World Health Summit (WHS) audience with greater urgency, alignment, and ambition to bring commitments and goals for AMR to fruition from a policy and systems perspective. By examining both achievements and obstacles, this session aims to foster collective action to mitigate AMR's impact on global health. Join us in navigating the complex landscape of AMR, celebrate progress, and address the roadblocks that remain.


 



Hosts:


Federal Ministry of Health of Germany (BMG)



Moderators:



Latifat Okara

Economist Impact | Principal for Health Policy and Insights | United States of America


 






Speakers:

Dr. Muna Abu Sin

Federal Ministry of Health (BMG) | Ambassador on Antimicrobial Resistance | Germany


 


 




Dr. Abdullah Algwizani

Public Health Authority | CEO | Saudi Arabia


 


 




Prof. Dame Sally Davies

UK Special Envoy on Antimicrobial Resistance | United Kingdom


 


 




Dr. Arshnee Moodley

CGIAR | Antimicrobial Resistance Hub | Lead | Kenya


 


 




Dr. David Reddy

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Director-General | Switzerland


 


 




Dr. John-Arne Røttingen

Wellcome Trust | CEO | United Kingdom


 


 




Prof. Dr. Orazio Schillaci

Minister of Health | Italy


Video Participation


 




Prof. Dr. Abdellahi Sidi Mohamed Weddih

Minister of Health | Mauritania




\n\n\n LOCATION: END:VEVENT END:VCALENDAR